The European Commission today approved DuPont’s €4.5bn offer for Danish probiotics, enzymes and ingredients giant Danisco but the deal remains in doubt as to date only 6% of Danisco shareholders have accepted the offer.
It's been on the cards since the fall, and now it's official: Pfizer has agreed to sell hard-capsule manufacturer Capsugel for $2.375 billion in cash to an affiliate of Kohlberg Kravis Roberts & Co L.P. (KKR).
A raft of higher-value products targeting humans rather than animals - from an ultra-potent antioxidant-rich rice bran oil to rice lecithin and food grade defatted rice bran – will help NutraCea puts its troubled past behind it in 2011/12, bosses have...
Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...
Rice bran ingredient and nutraceutical supplier NutraCea has emerged from Chapter 11 bankruptcy after just over a year – a move that allowed it to restructure and reduce overheads, the company has said.
Rice bran ingredient supplier NutraCea has said it expects to exit bankruptcy later this year after having filed for Chapter 11 protection in November to allow the company to restructure, reduce overheads and sell non-core assets.
Speculation about typical asset valuing ion the chemicals industry by Cognis’s chief financial officer, Marco Panichi, has led to a figure of €3.4bn being attached to the German ingredient company, as buy-out speculation mounts.